From Genentech β Oncology R&D Division Template by David Nagy Β· Templates
π SECTION 5: π Regulatory & Submission
Published
π FDA Interaction Log
Meeting summaries
Feedback
π IND / NDA Documentation
Key documents
Submission timeline
π Risk Mitigation Plans
Safety concerns
Regulatory strategies